HK Stock MarketDetailed Quotes
02616 CSTONE PHARMA-B
Watchlist
2.060
-0.100-4.63%
Trading 12/07 11:50 CST
2.160High2.050Low2.49MVolume
2.130Open2.160Pre Close5.19MTurnover0.19%Turnover RatioLossP/E (TTM)2.65BMarket Cap6.22052wk HighLossP/E (Static)1.28BShares1.62052wk Low4.04P/B2.65BFloat Cap19.120Historical High--Dividend TTM1.28BShs Float1.620Historical Low--Dividend LFY5.09%Amplitude--Div YieldTTM2.082Avg Price500Lot Size--Div Yield LFY
CSTONE PHARMA-B Key Stats
All
YOY

(Q6)2023/06/30 | (FY)2022/12/31 | (Q6)2022/06/30 | (FY)2021/12/31 | (Q6)2021/06/30 | (FY)2020/12/31 | (Q6)2020/06/30 | (FY)2019/12/31 | (Q6)2019/06/30 | (FY)2018/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | -63.68%19.58M | -63.84%22.19M | 78.81%53.9M | --61.36M | --30.14M | ---- | ---- | ---- | ---- | ---- |
Accounts receivable | 13.31%185.87M | -34.41%77.13M | 225.31%164.03M | --117.6M | --50.42M | ---- | ---- | ---- | ---- | ---- |
Advance deposits and other receivables | -85.64%23.38M | 101.56%105.51M | 35.88%162.81M | -70.60%52.35M | 12.11%119.82M | 23.98%178.04M | 102.12%106.88M | 205.63%143.6M | 54.47%52.88M | 520.91%46.98M |
Cash and equivalents | 23.89%906.22M | -24.78%558.68M | -70.11%731.46M | -75.44%742.72M | 41.10%2.45B | 168.51%3.02B | 4.44%1.73B | 60.61%1.13B | 17.76%1.66B | 741.03%701.34M |
Fixed time deposit-current assets | -73.14%99.15M | -43.84%483.41M | --369.13M | 139.84%860.72M | ---- | -77.56%358.87M | -76.74%389.37M | 110.12%1.6B | --1.67B | --761.22M |
Secured deposit | ---- | ---- | ---- | ---- | ---- | 16.13%720K | 16.13%720K | --620K | --620K | ---- |
Financial assets at fair value-current assets | ---- | ---- | 827.46%95.42M | 1,113.78%122.9M | -15.30%10.29M | --10.13M | 3.42%12.15M | ---- | -64.40%11.74M | -70.33%16.79M |
Special items of current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.69%16.76M | ---- | -80.23%78.62M |
Total current assets | -21.72%1.23B | -36.31%1.25B | -40.68%1.58B | -45.20%1.96B | 18.47%2.66B | 23.74%3.57B | -34.00%2.24B | 79.87%2.89B | 88.39%3.4B | 194.35%1.6B |
Non-current assets | ||||||||||
Property, plant and equipment | -19.68%130.17M | -10.24%138.38M | 342.50%162.06M | 291.61%154.17M | 64.74%36.62M | 177.53%39.37M | 73.42%22.23M | -1.99%14.19M | -12.07%12.82M | -6.37%14.47M |
Advance payment | ---- | ---- | -97.73%1.17M | -85.52%5.13M | 658.00%51.67M | 891.35%35.41M | 1,079.41%6.82M | 6,058.62%3.57M | 73.05%578K | -63.75%58K |
Financial assets at fair value-non-current assets | 7.66%3.61M | 9.22%3.48M | --3.36M | --3.19M | ---- | ---- | ---- | ---- | ---- | ---- |
Intangible assets | 25.07%217.47M | 126.40%159.7M | 178.42%173.88M | 983.71%70.54M | 833.39%62.45M | 398.77%6.51M | 689.96%6.69M | 45.48%1.31M | 5.22%847K | 304.05%897K |
Special items of non-current assets | -23.83%74.28M | 11.34%89.95M | 17.93%97.52M | -25.99%80.79M | 52.71%82.69M | 143.99%109.16M | 91.58%54.15M | 281.03%44.74M | 517.43%28.27M | 269.13%11.74M |
Total non-current assets | -2.84%425.54M | 24.76%391.51M | 87.62%437.99M | 64.77%313.81M | 159.70%233.44M | 198.50%190.45M | 111.46%89.89M | 134.83%63.8M | 109.46%42.51M | 42.85%27.17M |
Total assets | -17.62%1.66B | -27.87%1.64B | -30.32%2.01B | -39.63%2.27B | 23.91%2.89B | 27.52%3.76B | -32.21%2.33B | 80.79%2.95B | 88.63%3.44B | 189.24%1.63B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | -11.59%723.99M | -0.40%869.37M | 83.99%818.86M | 23.20%872.87M | 32.72%445.06M | 57.65%708.53M | 326.41%335.35M | 380.30%449.44M | 0.38%78.65M | 278.34%93.57M |
Bank loans and overdrafts | -66.34%9.95M | -72.09%8.57M | 485.06%29.56M | 1,053.27%30.7M | --5.05M | --2.66M | ---- | ---- | ---- | ---- |
Derivative financial instrument-current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,074.23%1.02B |
Financial lease liabilities-current liabilities | -28.76%31.89M | 174.39%36.35M | 359.26%44.76M | 53.12%13.25M | 509.19%9.75M | 99.17%8.65M | -72.28%1.6M | --4.34M | --5.77M | ---- |
Deferred income-current liabilities | -6.05%7M | -6.05%7M | 3.34%7.45M | 3.34%7.45M | 37.07%7.21M | 72.49%7.21M | --5.26M | --4.18M | ---- | ---- |
Other current liabilities | --30.28M | 190.37%25.2M | ---- | --8.68M | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --1.89M | ---- | ---- | ---- |
Total current liabilities | -10.83%803.1M | 1.45%946.48M | 92.82%900.63M | 28.32%932.95M | 35.74%467.07M | 58.76%727.05M | 307.61%344.1M | -58.71%457.96M | -82.31%84.42M | 879.64%1.11B |
Net current assets | -36.24%431.09M | -70.68%300.44M | -69.14%676.11M | -63.99%1.02B | 15.34%2.19B | 17.14%2.85B | -42.70%1.9B | 389.96%2.43B | 149.75%3.32B | 14.74%495.73M |
Total assets less current liabilities | -23.11%856.63M | -48.30%691.95M | -54.04%1.11B | -55.91%1.34B | 21.86%2.42B | 21.78%3.04B | -40.75%1.99B | 376.71%2.49B | 149.14%3.36B | 15.93%522.9M |
Non-current liabilities | ||||||||||
Long-term bank loan | 32.49%163.32M | 89.09%218.99M | 82.31%123.27M | 113.12%115.81M | 184.18%67.62M | --54.34M | --23.79M | ---- | ---- | ---- |
Long-term accounts payable | --75.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Financial lease liabilities-non-current liabilities | -63.23%14.41M | 55.04%22.39M | 158.19%39.2M | -20.69%14.44M | 14,785.29%15.18M | --18.21M | -92.76%102K | ---- | --1.41M | ---- |
Deferred income-non-current liabilities | ---- | 0.00%1.25M | -87.94%1.02M | -85.66%1.25M | -22.07%8.47M | -21.63%8.7M | 21.36%10.87M | 46.72%11.1M | --8.96M | --7.57M |
Total non-current liabilities | 54.70%252.92M | 84.51%242.62M | 79.13%163.49M | 61.86%131.5M | 162.51%91.27M | 631.98%81.24M | 235.34%34.77M | 46.72%11.1M | --10.37M | --7.57M |
Total liabilities | -0.76%1.06B | 11.71%1.19B | 90.59%1.06B | 31.69%1.06B | 47.37%558.34M | 72.32%808.29M | 299.70%378.86M | -58.00%469.06M | -80.13%94.79M | 886.32%1.12B |
Total assets less total liabilities | -36.49%603.72M | -62.77%449.33M | -59.25%950.6M | -59.15%1.21B | 19.36%2.33B | 19.06%2.95B | -41.61%1.95B | 381.55%2.48B | 148.38%3.35B | 14.25%515.33M |
Total equity and non-current liabilities | -23.11%856.63M | -48.30%691.95M | -54.04%1.11B | -55.91%1.34B | 21.86%2.42B | 21.78%3.04B | -40.75%1.99B | 376.71%2.49B | 149.14%3.36B | 15.93%522.9M |
Equity | ||||||||||
Share capital | 7.90%860K | 0.75%802K | 0.50%797K | 1.14%796K | 15.43%793K | 14.56%787K | 1.78%687K | 2,268.97%687K | 2,400.00%675K | 11.54%29K |
Reserve | -36.53%602.86M | -62.82%448.53M | -59.27%949.81M | -59.16%1.21B | 19.05%2.33B | 19.06%2.95B | -41.46%1.96B | 381.54%2.48B | 431.12%3.35B | 20.87%515.21M |
Legal reserve | -36.53%602.86M | -62.82%448.53M | -59.27%949.81M | -59.16%1.21B | 19.05%2.33B | 19.06%2.95B | -41.46%1.96B | 381.54%2.48B | 431.12%3.35B | 20.87%515.21M |
Special items of shareholders' rights and interests | -50.00%-9K | 81.82%-2K | 62.50%-6K | 42.11%-11K | 99.69%-16K | 36.67%-19K | -19,619.23%-5.13M | ---30K | ---26K | ---- |
Shareholders' Equity | -36.49%603.72M | -62.77%449.33M | -59.25%950.6M | -59.15%1.21B | 19.36%2.33B | 19.06%2.95B | -41.61%1.95B | 381.55%2.48B | 157.82%3.35B | 20.87%515.33M |
Total equity | -36.49%603.72M | -62.77%449.33M | -59.25%950.6M | -59.15%1.21B | 19.36%2.33B | 19.06%2.95B | -41.61%1.95B | 381.55%2.48B | 148.38%3.35B | 14.25%515.33M |
Total equity and total liabilities | -17.62%1.66B | -27.87%1.64B | -30.32%2.01B | -39.63%2.27B | 23.91%2.89B | 27.52%3.76B | -32.21%2.33B | 80.79%2.95B | 88.63%3.44B | 189.24%1.63B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--